These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34617579)

  • 1. [Moyamoya disease: revision and description of a number of pedriatic cases].
    Gonzalo-Alonso I; González-Montes NN; Nieto-Barceló JJ; Tomás-Vila M
    Rev Neurol; 2021 Oct; 73(8):261-266. PubMed ID: 34617579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Moyamoya disease: follow-up of 12 patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez R; Viaño J; Martínez V
    Neurologia; 2006 Dec; 21(10):695-703. PubMed ID: 17106822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Presentation and Stroke Incidence Differ by Moyamoya Etiology.
    Gatti JR; Torriente AG; Sun LR
    J Child Neurol; 2021 Mar; 36(4):272-280. PubMed ID: 33155871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple arterial ischemic strokes in a child with moyamoya disease and Mycoplasma pneumoniae infection].
    Greco F; Castellano Chiodo D; Sorge A; Perrini S; Sorge G
    Minerva Pediatr; 2006 Feb; 58(1):63-8. PubMed ID: 16541008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Moyamoya Angiopathy in a Pediatric Cohort.
    Pines AR; Rodriguez D; Bendok BR; Dhamija R
    J Child Neurol; 2020 May; 35(6):389-392. PubMed ID: 32089044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine.
    Marcinkevicius E; Liutkus D; Gvazdaitis A
    Medicina (Kaunas); 2006; 42(2):130-6. PubMed ID: 16528129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke after adenotonsillectomy in patients with undiagnosed moyamoya syndrome.
    Ahn AK; Honeybrook A; Jordan LC; Singer RJ; Tylor DA
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1061-4. PubMed ID: 25257069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Moyamoya disease. A cause of vascular occlusion in childhood].
    Pineda Sánchez J; Palomeque Rico A; Cambra Lasaosa FJ; Caritg Bosch J; Martín Rodrigo JM; Campistol Plana J; Fernández-Alvarez E
    An Esp Pediatr; 1999 Jan; 50(1):44-8. PubMed ID: 10083642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.
    Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moyamoya disease: an elusive diagnosis.
    Asumal KB; Akhtar N; Syed NA; Shafqat S; Baig SM
    J Pak Med Assoc; 2003 Apr; 53(4):160-2. PubMed ID: 12776902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moyamoya disease: a summary.
    Burke GM; Burke AM; Sherma AK; Hurley MC; Batjer HH; Bendok BR
    Neurosurg Focus; 2009 Apr; 26(4):E11. PubMed ID: 19335127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moyamoya disease in a Moroccan baby: a case report.
    Houba A; Laaribi N; Meziane M; Jaafari A; Abouelalaa K; Bensghir M
    J Med Case Rep; 2018 Jun; 12(1):165. PubMed ID: 29895322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.